Literature DB >> 16388368

Multiple sclerosis and lifestyle factors: the Hordaland Health Study.

M W Nortvedt1, T Riise, J G Maeland.   

Abstract

This study compared multiple sclerosis (MS) patients (n=87) with the general population and with people reporting angina pectoris (n=109), asthma (n=1,353) and diabetes (n=219) regarding health-related quality of life (SF-12), working status and lifestyle factors including smoking, alcohol consumption, body mass index (BMI) and leisure physical activity. The study was cross-sectional and included the birth cohorts from 1950 to 1957 living in Hordaland County, Norway in 1997. A total of 22,312 people participated, yielding a response rate of 65%. The MS patients had a high rate of smoking and a low mean BMI, despite lower leisure physical activity compared with the rest of the study population. This suggests that it may be advisable to increase the focus on smoking, physical activity and the balance between energy intake and use.

Entities:  

Mesh:

Year:  2005        PMID: 16388368     DOI: 10.1007/s10072-005-0498-2

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  24 in total

1.  Caffeine and alcohol intakes have no association with risk of multiple sclerosis.

Authors:  J Massa; E J O'Reilly; K L Munger; A Ascherio
Journal:  Mult Scler       Date:  2012-05-28       Impact factor: 6.312

2.  Pregnancy, delivery and birth outcome in different stages of maternal multiple sclerosis.

Authors:  Julie Dahl; Kjell-Morten Myhr; Anne Kjersti Daltveit; Nils Erik Gilhus
Journal:  J Neurol       Date:  2008-02-19       Impact factor: 4.849

3.  Increased prevalence of multiple sclerosis among COPD patients and their first-degree relatives: a population-based study.

Authors:  Arne Egesten; Lena Brandt; Tomas Olsson; Fredrik Granath; Malin Inghammar; Claes-Göran Löfdahl; Anders Ekbom
Journal:  Lung       Date:  2008-03-20       Impact factor: 2.584

4.  Association between alcohol consumption and multiple sclerosis: a meta-analysis of observational studies.

Authors:  Tiantian Zhu; Xiaofei Ye; Tianyi Zhang; Zhiyong Lin; Wentao Shi; Xin Wei; Yuzhou Liu; Jia He
Journal:  Neurol Sci       Date:  2015-07-10       Impact factor: 3.307

Review 5.  Influence of Diet in Multiple Sclerosis: A Systematic Review.

Authors:  M José Bagur; M Antonia Murcia; Antonia M Jiménez-Monreal; Josep A Tur; M Mar Bibiloni; Gonzalo L Alonso; Magdalena Martínez-Tomé
Journal:  Adv Nutr       Date:  2017-05-15       Impact factor: 8.701

6.  Variation within DNA repair pathway genes and risk of multiple sclerosis.

Authors:  Farren B S Briggs; Benjamin A Goldstein; Jacob L McCauley; Rebecca L Zuvich; Philip L De Jager; John D Rioux; Adrian J Ivinson; Alastair Compston; David A Hafler; Stephen L Hauser; Jorge R Oksenberg; Stephen J Sawcer; Margaret A Pericak-Vance; Jonathan L Haines; Lisa F Barcellos
Journal:  Am J Epidemiol       Date:  2010-06-03       Impact factor: 4.897

7.  Leisure time physical activity and risk of non-vertebral fracture in men and women aged 55 years and older: the Tromsø Study.

Authors:  Bente Morseth; Luai A Ahmed; Åshild Bjørnerem; Nina Emaus; Bjarne K Jacobsen; Ragnar Joakimsen; Jan Størmer; Tom Wilsgaard; Lone Jørgensen
Journal:  Eur J Epidemiol       Date:  2012-03-04       Impact factor: 8.082

Review 8.  The epidemiology of alcohol consumption and multiple sclerosis: a review.

Authors:  Yu-Jie Wang; Rui Li; Jun-Wei Yan; Ya-Nan Wan; Jin-Hui Tao; Bing Chen; Xiao-Lei Huang; Guo-Jun Yang; Jing Wang; Dong-Qing Ye
Journal:  Neurol Sci       Date:  2014-11-12       Impact factor: 3.307

9.  Body size and risk of MS in two cohorts of US women.

Authors:  Kassandra L Munger; Tanuja Chitnis; Alberto Ascherio
Journal:  Neurology       Date:  2009-11-10       Impact factor: 9.910

Review 10.  Moderate alcohol drinking might be protective for systemic lupus erythematosus: a systematic review and meta-analysis.

Authors:  Jing Wang; Hai-Feng Pan; Dong-Qing Ye; Hong Su; Xiang-Pei Li
Journal:  Clin Rheumatol       Date:  2008-09-16       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.